Koh Bong Y's Form 4 filing
Oruka Therapeutics, Inc. (ORKA) · filed Feb 27, 2025
- Accession no.
- 0001415889-25-005908
- Filed
- Feb 27, 2025, 6:42 PM ET
- Trade date
- Feb 10-14, 2025
- Filing delay
- 17 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.41M. It was filed 17 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Koh Bong YCIK 0001615979 | 10% Owner |
| Shah Nimish PCIK 0001698082 | 10% Owner |
| Venrock Healthcare Capital Partners III, L.P.CIK 0001738048 | 10% Owner |
| VHCP Management III, LLCCIK 0001738053 | 10% Owner |
| VHCP Co-Investment Holdings III, LLCCIK 0001750761 | 10% Owner |
| Venrock Healthcare Capital Partners EG, L.P.CIK 0001808512 | 10% Owner |
| VHCP Management EG, LLCCIK 0001808518 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2025 | Common Stock | PPurchaseAcquired | +574 | $10.90 | +$6,256.6 | 4,026,120 | Indirect | |
| Feb 11, 2025 | Common Stock | PPurchaseAcquired | +9,593 | $10.95 | +$105,043.35 | 4,035,713 | Indirect | |
| Feb 12, 2025 | Common Stock | PPurchaseAcquired | +8,971 | $11.86 | +$106,396.06 | 4,044,684 | Indirect | |
| Feb 13, 2025 | Common Stock | PPurchaseAcquired | +14,950 | $11.63 | +$173,868.5 | 4,059,634 | Indirect | |
| Feb 14, 2025 | Common Stock | PPurchaseAcquired | +88,794 | $11.44 | +$1,015,803.36 | 4,148,428 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.